Rationale and design of a prospective, multicentre, randomised, conventional treatment-controlled, parallel-group trial to evaluate the efficacy and safety of ulinastatin in preventing acute respiratory distress syndrome in high-risk patients.

Name: Rationale and design of a prospective, multicentre, randomised, conventional treatment-controlled, parallel-group trial to evaluate the efficacy and safety of ulinastatin in preventing acute respiratory distress syndrome in high-risk patients.
Author: Wang, Zongyu

Rationale and design of a prospective, multicentre, randomised, conventional treatment-controlled, parallel-group trial to evaluate the efficacy and safety of ulinastatin in preventing acute respiratory distress syndrome in high-risk patients. — المؤلف: Wang, Zongyu — BMJ open 20200330

المؤلف: Wang, Zongyu
النشر: BMJ open 20200330
الوصف: e025523 p.
الموضوعات: Anti-Inflammatory Agents؛ Glycoproteins؛ Humans؛ Infusions, Intravenous؛ Multicenter Studies as Topic؛ Outcome Assessment, Health Care؛ Prospective Studies؛ Randomized Controlled Trials as Topic